Publications

Status: 20/12/2023

Please find our publications sorted by year below: Please click on the year to see the papers published in that year.

2023

  1. Kasteler R, Otth M, Florian S. Halbeisen FS, Mader L, Singer F, Rössler J, von der Weid NX, Ansari M, Kuehni CE. Longitudinal assessment of lung function in Swiss childhood cancer survivors—A multicenter cohort study. Pediatr Pulmo. 2023. 10.1002/ppul.26738
  2. Heymer EJ, Jóźwiak K, Kremer LCM, Winter DL, de Vathaire F, Sunguc C, Sugden E, Kok JL, van der Pal H, Hjorth L, Jakab Z, Maule MM, Haupt R, Terenziani M, Winther Gunnes M, Sommer G, Zadravec Zaletel L, Kuehni CE, Winther JF, Lähteenmäki PM, Gudmunsdottir T, Allodji R, Skinner R, Ronckers CM, Hawkins MM, Reulen RC, Teepen JC. Cumulative absolute risk of subsequent colorectal cancer after abdominopelvic radiotherapy among childhood cancer survivors using a clinically accessible metric: a PanCareSurFup Study. J Clin Oncol. In press.
  3. Belle FN, Schindera C, Ansari M, Armstrong GT, Beck-Popovic M, Howell R, Leisenring WM, Meacham LR, Rössler J, Spycher BD, Tonorezos E, von der Weid NX, Yasui Y, Oeffinger KC, Kuehni CE. Risk factors for overweight and obesity after childhood acute lymphoblastic leukemia in North America and Switzerland: A comparison of two cohort studies. Cancer Med. 2023;12:20423-20439. 10.1002/cam4.6588
  4. Sláma T, Belle FN, Strebel S, Christen S, Hägler-Laube E, Rössler J, Kuehni CE, von der Weid NX, Schindera C. Prevalence and factors associated with cancer-related fatigue in Swiss adult survivors of childhood cancer. J Cancer Surviv. 2023. 10.1007/s11764-023-01413-1
  5. Strebel S, Baust K, Grabow D, Byrne J, Langer T, am Zehnhoff-Dinnesen A, Kuonen R, Weiss A, Kepak T, Kruseova J, Berger C, Calaminus G, Sommer G, Kuehni CE; PanCareLIFE Consortium. Auditory complications among childhood cancer survivors and health-related quality of life: a PanCareLIFE study. J Cancer Surviv. 2023. 10.1007/s11764-023-01456-4
  6. Wang Y, Ronckers CM, van Leeuwen FE, Moskowitz CS, Leisenring W, Armstrong GT, de Vathaire F, Hudson MM, Kuehni CE, Arnold MA, Demoor-Goldschmidt C, Green DM, Henderson TO, Howell RM, Ehrhardt MJ, Neglia JP, Oeffinger KC, van der Pal HJH, Robison LL, Schaapveld M, Turcotte LM, Waespe N, Kremer LCM, Teepen JC; The International Consortium for Pooled Studies on Subsequent Malignancies after Childhood and Adolescent Cancer. Subsequent female breast cancer risk associated with anthracycline chemotherapy for childhood cancer. Nat Med. 2023;29:2268–2277. 10.1038/s41591-023-02514-1 
  7. Strebel S, Mader L, Jörger P, Waespe N, Uhlmann S, Von Der Weid N, Ansari M, Kuehni CE. Hearing loss after exposure to vincristine and platinum-based chemotherapy among childhood cancer survivors. EJC Paediatric Oncology. 2023;1:100017. 10.1016/j.ejcped.2023.100017
  8. Scobioala S, Parfitt R, Matulat P, Byrne J, Langer T, Troschel FM, Hesping AE, Clemens E, Kaatsch P, Grabow D, Kaiser M, Spix C, Kremer LC, Calaminus G, Baust K, Kuehni CE, Weiss A, Strebel S, Kuonen R, Elsner S, Haupt R, Garré M-L, Gruhn B, Kepak T, Kepakova K, Falck Winther J, Kenborg L, Rechnitzer C, Hasle H, Kruseova J, Luks A, Lackner H, Bielack S, Beck J-D, Jürgens H, van den Heuvel-Eibrink MM, Zolk O, Eich HT, am Zehnhoff-Dinnesen A; on behalf of the PanCareLIFE Consortium. The impact of the temporal sequence of cranial radiotherapy and platin-based chemotherapy on hearing impairment in pediatric and adolescent CNS and head-and-neck cancer patients: A report from the PanCareLIFE consortium. Int J Cancer. 2023:1-12. 10.1002/ijc.34732
  9. Reulen RC, Winter DL, Diallo I, Veres C, Llanas D, Allodji RS, Bagnasco F, Bárdi E, Feijen EAM, Alessi D, Fidler-Benaoudia MM, Høgsholt S, Teepen JC, Linge H, Haddy N, Byrne J, Debiche G, Grabow D, Gudmundsdottir T, Fauchery R, Zrafi W, Michel G, Øfstaas H, Kaatsch P, Vu-Bezin G, Jenkinson H, Kaiser M, Skinner R, Cole T, Waespe N, Sommer G, Nordenfelt S, Jankovic M, Lähteenmäki Taalas T, Maule MM, van der Pal HJH, Ronckers CM, van Leeuwen FE, Kok JL, Terenziani M, Winther Gunnes M, Wiebe T, Sacerdote C, Jakab Z, Haupt R, Lähteenmäki PM, Zadravec Zaletel L, Kuehni CE, Falck Winther J, Kremer LCM, Hjorth L, de Vathaire F, Hawkins MM. Risk Factors for Primary Bone Cancer After Childhood Cancer: A PanCare Childhood and Adolescent Cancer Survivor Care and Follow-Up Studies Nested Case-Control Study. J Clin Oncol 2023;41(21):3735-3746. 10.1200/JCO.22.02045
  10. Dudley IM, Sunguc C, Heymer EJ, Winter DL, Teepen JC, Belle FN, Bárdi E, Bagnasco F, Gudmundsdottir T, Skinner R, Michel G, Byrne J, Øfstaas H, Jankovic M, Česen Mazić M, Mader L, Loonen J, Garwicz S, Wiebe T, Alessi D, Allodji RS, Haddy N, Grabow D, Kaatsch P, Kaiser M, Maule MM, Jakab Z, Winther Gunnes M, Terenziani M, Zadravec Zaletel L, Kuehni CE, Haupt R, Florent de Vathaire F Kremer LC, Lähteenmäki PM, Winther JF, Hjorth L, Hawkins MM, Reulen RC. Risk of subsequent primary lymphoma in a cohort of 69,460 five-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study. Cancer. 2023;129(3):426-440. 10.1002/cncr.34561
  11. de Baat EC, Feijen EAM, Reulen RC, Allodji RS, Bagnasco F, Bardi E, Belle FN, Byrne J, van Dalen EC, Debiche G, Diallo I, Grabow D, Hjorth L, Jankovic M, Kuehni CE, Levitt G, Llanas D, Loonen J, Zaletel LZ, Maule MM, Miligi L, van der Pal HJH, Ronckers CM, Sacerdote C, Skinner R, Jakab Z, Veres C, Haddy N, Winter DL, de Vathaire F, Hawkins MM, Kremer LCM. Risk Factors for Heart Failure Among Pan-European Childhood Cancer Survivors: A PanCareSurFup and ProCardio Cohort and Nested Case-Control Study. J Clin Oncol. 2023;41(1):96-106. 10.1200/JCO.21.02944
  12. Sunguc C, Hawkins MM, Winter DL, Dudley IM, Heymer EJ, Teepen JC, Allodji RS, Belle FN, Bagnasco F, Byrne J, Bárdi E, Ronckers CM, Haddy N, Gudmundsdottir T, Garwicz S, Jankovic M, van der Pal HJH, Mazić MČ, Schindera C, Grabow D, Maule MM, Kaatsch P, Kaiser M, Fresneau B, Michel G, Skinner R, Wiebe T, Sacerdote C, Jakab Z, Gunnes MW, Terenziani M, Winther JF, Lähteenmäki PM, Zaletel LZ, Kuehni CE, Kremer LC, Haupt R, de Vathaire F, Hjorth L, Reulen RC. Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study. Br J Cancer. 2023 Jan;128(1):80-90. 10.1038/s41416-022-02016-w

2022

  1. Wang Y, Kremer LCM, van Leeuwen FE For the International Consortium for Pooled Studies on Subsequent Malignancies after Childhood and Adolescent Cancer, et al. Cohort profile: Risk and risk factors for female breast cancer after treatment for childhood and adolescent cancer: an internationally pooled cohort. BMJ Open 2022;12:e065910. https://doi.org/10.1136/bmjopen-2022-065910
  2. Yuehan Wang, Raoul C. Reulen, Leontien C.M. Kremer, Florent de Vathaire, Riccardo Haupt, Lorna Zadravec Zaletel, Francesca Bagnasco, Charlotte Demoor-Goldschmidt, Willem J. van Dorp, Nadia Haddy, Lars Hjorth, Zsuzsanna Jakab, Claudia E. Kuehni, Päivi M. Lähteenmäki, Helena J.H. van der Pal, Carlotta Sacerdote, Roderick Skinner, Monica Terenziani, Finn Wesenberg, Jeanette F. Winther, Flora E. van Leeuwen, Mike M. Hawkins, Jop C. Teepen, Elvira C. van Dalen, Cécile M. Ronckers (2022). Male breast cancer after childhood cancer: Systematic review and analyses in the PanCareSurFup cohort. European Journal of Cancer,165, 27-47, https://doi.org/10.1016/j.ejca.2022.01.001
  3. Otth, M., Yammine, S., Usemann, J., Latzin, P., Mader, L., Spycher, B., Güngör, T., Scheinemann, K., Kuehni, C.E., Ansari, M., Beck Popovic, M., Bourquin, J.P., Brazzola, P., Greiner, J., Rössler, J., Schilling, F., Scheinemann, K., Von Der Weid, N., 2022. Longitudinal lung function in childhood cancer survivors after hematopoietic stem cell transplantation. Bone Marrow Transplantation 57, 207–214. https://doi.org/10.1038/s41409-021-01509-1
  4. Byrne, J, Schmidtmann, I, Rashid, H, et al. Impact of era of diagnosis on cause-specific late mortality among 77 423 five-year European survivors of childhood and adolescent cancer: The PanCareSurFup consortium. Int J Cancer. 2022; 150(3): 406-419. https://doi.org/10.1002/ijc.33817
  5. Belle, FN et al. Body image in adolescent survivors of childhood cancer: The role of chronic health conditions. Pediatr Blood Cancer. 2022; e29958.  https://doi.org/10.1002/pbc.29958
  6. Strebel et al. Severity of hearing loss after platinum chemotherapy in childhood cancer survivors. Pediatr Blood Cancer. 2022; 69:e29755. https://doi.org/10.1002/pbc.29755
  7. Mader et al. Social, emotional, and behavioral functioning in young childhood cancer survivors with chronic health conditions. Pediatr Blood Cancer 2022. https://onlinelibrary.wiley.com/doi/10.1002/pbc.29756

2021

  1. Reulen et al. Risk of digestive cancers in a cohort of 69 460 five-year survivors of childhood cancer in Europe: the PanCareSurFup study. Gut. 2020 Nov 2:gutjnl-2020-322237. https://doi.org/10.1136/gutjnl-2020-322237. Epub ahead of print.
  2. Byrne et al. Impact of era of diagnosis on cause-specific late mortality among 77,423 five-year European survivors of childhood and adolescent cancer: the PanCareSurFup consortium. Int J Cancer. 2021. https://doi.org/10.1002/ijc.33817.
  3. Otth et al. Longitudinal lung function in childhood cancer survivors after hematopoietic stem cell transplantation-a cohort study. Bone Marrow Transplant. 2021. https://doi.org/10.1038/s41409-021-01509-1.  
  4. Kaatsch et al. Managing a pan-European consortium on late effects among long-term survivors of childhood and adolescent cancer – the PanCareLIFE project. Int J Environ Res Public Health. 2021; 18: 3918. https://doi.org/10.3390/ijerph18083918.
  5. Kastele et al. Validation of questionnaire-reported chest wall abnormalities with a telephone interview in Swiss childhood cancer survivors. BMC Cancer. 2021; 21:787. https://doi.org/10.1186/s12885-021-08425-z.
  6. Belle et al. Dietary Intake and Diet Quality of Adult Survivors of Childhood Cancer and the General Population: Results from the SCCSS-Nutrition Study. Nutrients. 2021; 13(6):1767. https://doi.org/10.3390/nu13061767. Please click on the link to read the summary of the findings of this paper.
  7. Waespe et al. Genetic Predictors for Sinusoidal Obstruction Syndrome-A Systematic Review. J Pers Med. 2021 Apr 26;11(5):347. https://doi.org/10.3390/jpm11050347.
  8. Mader et al. Hospital Contacts for Psychiatric Disorders in Parents of Children with Cancer in Denmark, JNCI Cancer Spectrum, 2021;, pkab036, https://doi.org/10.1093/jncics/pkab036.
  9. Strebel et al. Hearing loss in childhood cancer survivors. Lancet Child Adolesc Health. 2021 May;5(5):e17. https://doi.org/10.1016/S2352-4642(21)00099-7. [Correspondance]
  10. Schindera et al. Pulmonary Dysfunction after Treatment for Childhood Cancer. Comparing Multiple-Breath Washout with Spirometry. Ann Am Thorac Soc. 2021 Feb;18(2):281-289. https://doi.org/10.1513/AnnalsATS.202003-211OC.
  11. Calaminus et al. Health-Related Quality of Life in European Childhood Cancer Survivors: Protocol for a Study Within PanCareLIFE. JMIR Res Protoc. 2021 Jan 25;10(1):e21851. https://doi.org/10.2196/21851.
  12. Waespe et al. Cancer predisposition syndromes as a risk factor for early second primary neoplasms after childhood cancer – A national cohort study. Eur J Cancer. 2021 Jan 7;145:71-80. https://doi.org/10.1016/j.ejca.2020.11.042.
  13. Feijen et al. Increased risk of cardiac ischaemia in a pan-European cohort of 36 205 childhood cancer survivors: a PanCareSurFup study. Heart. 2021 Jan;107(1):33-40. https://doi.org/10.1136/heartjnl-2020-316655.

2020

  1. Otth et al. Transplant characteristics and self-reported pulmonary outcomes in Swiss childhood cancer survivors after hematopoietic stem cell transplantation-a cohort study. Bone Marrow Transplant. 2020;10.1038/s41409-020-01137-1. https://doi.org/10.1038/s41409-020-01137-1.
  2. Verbruggen et al. Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatr Blood Cancer. 2020 Dec;67(12):e28702. https://doi.org/10.1002/pbc.28702.
  3. Norsker et al. Late Effects in Childhood Cancer Survivors: Early Studies, Survivor Cohorts, and Significant Contributions to the Field of Late Effects. Pediatr Clin North Am. 2020 Dec;67(6):1033-1049. https://doi.org/10.1016/j.pcl.2020.07.002.
  4. Waszak et al. Germline Elongator mutations in Sonic Hedgehog medulloblastoma. Nature. 2020 Apr;580(7803):396-401. https://doi.org/10.1038/s41586-020-2164-5.
  5. Visscher et al. Cardiovascular and Pulmonary Challenges After Treatment of Childhood Cancer. Pediatr Clin North Am. 2020 Dec;67(6):1155-1170. https://doi.org/10.1016/j.pcl.2020.07.007.
  6. Langer et al. Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study. Eur J Cancer. 2020 Oct;138:212-224. https://doi.org/10.1016/j.ejca.2020.07.019.
  7. Langer et al. Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset. Data Brief. 2020 Aug 24;32:106227. https://doi.org/10.1016/j.dib.2020.106227.
  8. Schindera et al. Diagnosing Preclinical Cardiac Dysfunction in Swiss Childhood Cancer Survivors: Protocol for a Single-Center Cohort Study. JMIR Res Protoc. 2020 Jun 10;9(6):e17724. https://doi.org/10.2196/17724.
  9. Konstantinoudis et al. Bayesian spatial modelling of childhood cancer incidence in Switzerland using exact point data: a nationwide study during 1985-2015. Int J Health Geogr. 2020 Apr 17;19(1):15. https://doi.org/10.1186/s12942-020-00211-7.
  10. Belle et al. Sodium and potassium intake and cardiovascular disease in childhood cancer survivors: the SCCSS-Nutrition study. Nutrients, 2020;12(57); https://doi.org/10.3390/nu12010057.
  11. Schindera et al. Physical activity and screen time in children who survived cancer – A report from the Swiss Childhood Cancer Survivor Study. Pediatr Blood Cancer, 2020 Feb;67(2):e28046. https://doi.org/10.1002/pbc.28046.

2019

  1. Clemens et al.Genetic variation of cisplatin-induced ototoxicity in non-cranial-irradiated pediatric patients using a candidate gene approach: The International PanCareLIFE Study. Pharmacogenomics J. 2020 Apr;20(2):294-305. https://doi.org/10.1038/s41397-019-0113-1.
  2. Belle et al. Nutritional assessment in childhood cancer survivors: Swiss Childhood Cancer Survival Study-Nutrition study protocol. JMIR Res Protoc, 2019;8(11):e14427. http://dx.doi.org/10.2196/14427
  3. Roser et al. Health-related quality of life in Switzerland: normative data for the SF-36v2 questionnaire. Quality of Life Research. 2019;28(7):1963-77. https://doi.org/10.1007/s11136-019-02161-5
  4. Sommer et al. Temporal trends in incidence of childhood cancer in Switzerland, 1985-2014. Cancer Epidemiol. 2019 Aug;61:157-164. https://doi.org/10.1016/j.canep.2019.06.002.  
  5. Allodji et al. Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe: A cohort study within PanCareSurFup. Eur J Cancer. 2019 Aug;117:71-83. https://doi.org/10.1016/j.ejca.2019.05.013.
  6. Clemens et al. Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE Study. JMIR Res Protoc. 2019;8(3):e11868. https://doi.org/10.2196/11868
  7. Hau et al. Cardiovascular disease after childhood acute lymphoblastic leukemia: a cohort study. Swiss Med Wkly. 2019;149:w20012. https://doi.org/10.4414/smw.2019.20012
  8. Essig et al. Communicating “cure” to pediatric oncology patients: A mixed methods study. Pediatr Blood & Cancer. 2019:e27661. https://doi.org/10.1002/pbc.27661.
  9. Belle et al. Overweight in childhood cancer patients at diagnosis and throughout therapy: A multicentre cohort study. Clin Nutr. 2019a;38(2):835-841. https://doi.org/10.1016/j.clnu.2018.02.022.
  10. Swerdlow et al. Risk of Meningioma in European Patients Treated With Growth Hormone in Childhood: Results From the SAGhE Cohort. J Clin Endocrinol Metab. 2019;104(3):658-64. https://doi.org/10.1210/jc.2018-01133.
  11. Kasteler et al. Prevalence and reasons for smoking in adolescent Swiss childhood cancer survivors. Pediatr Blood & Cancer. 2019;66(1):e27438. https://doi.org/10.1002/pbc.27438.
  12. Christen et al. Perceived information provision and information needs in adolescent and young adult cancer survivors. European Journal of Cancer Care. 2019;28(1),e12892. https://doi.org/10.1111/ecc.12892.
  13. Clemens et al. Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium. Lancet Oncol. 2019;20(1):e29-e41. https://doi.org/10.1016/S1470-2045(18)30858-1.
  14. Weiss et al. Hearing loss and quality of life in survivors of paediatric CNS tumours and other cancers. Qual Life Res. 2019;28(2):515-521. https://doi.org/10.1007/s11136-018-2021-2.

2018

  1. Tonorezos et al. Models of Care for Survivors of Childhood Cancer From Across the Globe: Advancing Survivorship Care in the Next Decade. J Clin Oncol. 2018;36(21):2223-30. https://doi.org/10.1200/JCO.2017.76.5180.
  2. Harju et al. Health-related quality of life in adolescent and young adult cancer survivors. Support Care Cancer. 2018 Sep;26(9):3099-3110. https://doi.org/10.1007/s00520-018-4151-z.
  3. Kasteler et al. Monitoring pulmonary health in Swiss childhood cancer survivors. Pediatr Blood & Cancer. 2018a;65(10):e27255. https://doi.org/10.1002/pbc.27255.
  4. Van den Berg et al. Fertility Among Female Survivors of Childhood, Adolescent, and Young Adult Cancer: Protocol for Two Pan European Studies (PanCareLIFE). JMIR Res Protoc. 2018;7(9):e10824. https://doi.org/10.2196/10824.
  5. Harju et al. Health related quality of life in adolescent and young adult cancer survivors. Supportive Care in Cancer. 2018;26(9),3099-3110. https://doi.org/10.1007/s00520-018-4151-z.
  6. Allemani et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023-75. https://doi.org/10.1016/S0140-6736(17)33326-3.
  7. Baenziger et al. Can the Theory of Planned Behavior help explain attendance to follow-up care of childhood cancer survivors? Psycho-Oncology. 2018;27(6).1501–1508. https://doi.org/10.1002/pon.4680.
  8. Bright et al. Risk of Soft-Tissue Sarcoma Among 69 460 Five-Year Survivors of Childhood Cancer in Europe. J Natl Cancer Inst.; 2018; 110(6):649-60. https://doi.org/10.1093/jnci/djx235.
  9. Waszak et al. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. Lancet Oncol. 2018;19(6):785-98. https://doi.org/10.1016/S1470-2045(18)30242-0.
  10. Jankovic et al. Long-term survivors of childhood cancer: cure and care-the Erice Statement (2006) revised after 10 years (2016). J Cancer Surviv. 2018;12(5):647-50. https://doi.org/10.1007/s11764-018-0701-0.
  11. Roser et al. Attendance to follow up-care in adolescent and young adult cancer survivors: application of the Theory of Planned Behavior. Journal of Adolescent and Young Adult Oncology. 2018;7(5),584-591. https://doi.org/10.1089/jayao. 2018.0010.
  12. Amoon et al.Proximity to overhead power lines and childhood leukaemia: an international pooled analysis. Br J Cancer. 2018;119(3):364-373. https://doi.org/10.1038/s41416-018-0097-7.
  13. Konstantinoudis et al. Spatial clustering of childhood cancers inSwitzerland: a nationwide study. Cancer Causes Control. 2018;29(3):353-62. https://doi.org/10.1007/s10552-018-1011-6.
  14. Weiss et al. Audiological monitoring in Swiss childhood cancer patients. Pediatr Blood & Cancer. 2018;65(3):e26877. https://doi.org/10.1002/pbc.26877.
  15. Grabow et al. The PanCareSurFup cohort of 83,333 five-year survivors of childhood cancer: a cohort from 12 European countries. Eur J Epidemiol. 2018;33(3):335-49. https://doi.org/10.1007/s10654-018-0370-3.
  16. Vetsch et al. Parents’ preferences for the organization of long-term follow-up of childhood cancer survivors. European Journal of Cancer Care. 2018;27(2). https://doi.org/10.1111/ecc.12649.
  17. Belle et al. Overweight in childhood cancer survivors: the Swiss Childhood Cancer Survivor Study. Am J Clin Nutr. 2018a;107(1):3-11. https://doi.org/10.1093/ajcn/nqx006.
  18. Belle et al. No evidence of overweight in long-term survivors of childhood cancer after glucocorticoid treatment. Cancer. 2018b;124:3576-85. https://doi.org/10.1002/cncr.31599.
  19. Fidler et al. Risk of Subsequent Bone Cancers Among 69 460 Five-Year Survivors of Childhood and Adolescent Cancer in Europe. J Natl Cancer Inst. 2018;110(2). https://doi.org/10.1093/jnci/djx165.
  20. Kasteler et al. Long-term pulmonary disease among Swiss childhood cancer survivors. Pediatr Blood & Cancer. 2018b;65(1):e26749. https://doi.org/10.1002/pbc.26749.
  21. Byrne et al. PanCareLIFE: The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity and health-related quality of life after cancer occurring among children and adolescents. Eur J Cancer. 2018;103:227-37.33. https://doi.org/10.1016/j.ejca.2018.08.007.
  22. Byrne et al. The PanCareSurFup consortium: research and guidelines to improve lives for survivors of childhood cancer. Eur J Cancer. 2018;103:238-48. https://doi.org/10.1016/j.ejca.2018.08.017.
  23. Clemens et al. Genetic determinants of ototoxicity during and after childhood cancer treatment: design of PanCareLIFE studies. JMIR, BMC Cancer. 2018. https://doi.org/10.2196/11868.
  24. Nikkila et al. Effects of incomplete residential histories on studies of environmental exposure with application to childhood leukaemia and background radiation. Environ Res. 2018;166:466-72. https://doi.org/10.1016/j.envres.2018.06.035.
  25. Van der Kooi et al. Genetic variation in gonadal impairment in female survivors of childhood cancer: a PanCareLIFE study protocol. BMC Cancer, 2018;18(1): 930. https://doi.org/10.1186/s12885-018-4834-3.

2017

  1. Mader et al. Education, employment and marriage in long-term survivors of teenage and young adult cancer compared with healthy controls. Swiss Med Wkly. 2017a;147:314419. https://doi.org/10.4414/smw.2017.14419.
  2. Bonaventure et al. Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries. Lancet Haematol. 2017;4(5):e202-e17. https://doi.org/10.1016/S2352-3026(17)30052-2.
  3. Kreis et al. Space-Time Clustering of Childhood Leukemia: Evidence of an Association with ETV6-RUNX1 (TEL-AML1) Fusion. PLoS One, 2017;12(1):e0170020. https://doi.org/
  4. Konstantinoudis et al. Spatial clustering of childhood leukaemia in Switzerland: A nationwide study. Int J Cancer, 2017;141(7):1324-32. https://doi.org/10.1371/journal.pone.0170020.
  5. Vetsch et al. Parents’ preferences for the organization of long-term follow-up of childhood cancer survivors. Eur J Cancer Care 2017a; https://doi.org/10.1111e12649.
  6. Belle et al. Low adherence to dietary recommendations in adult childhood cancer survivors. Clinical Nutrition. 2017;36(5):1266-74. https://doi.org/10.1016/j.clnu.2016.08.012.
  7. Schindler et al. Childhood cancer survival in Switzerland (1976-2013): Time-trends and predictors. Int J Cancer. 2017;140:62-74. https://doi.org/10.1002/ijc.30434.
  8. Weiss et al. Validation of questionnaire-reported hearing with medical records: A report from the Swiss Childhood Cancer Survivor Study. PLoS One. 2017;12(3):e0174479. https://doi.org/10.1371/journal.pone.0174479.
  9. Weiss et al. Long- term auditory complications after childhood cancer: A report from the Swiss Childhood Cancer Survivor Study. Pediatr Blood & Cancer. 2017;64(2):364-373. https://doi.org/10.1002/pbc.26212.
  10. Rueegg et al. No evidence of response bias in a population-based childhood cancer survivor questionnaire survey – Results from the Swiss Childhood Cancer Survivor Study. Plos ONE. 2017;12(5):e0176442. https://doi.org/10.1371/journal.pone.0176442.
  11. Swerdlow et al. Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study. J Clin Endocrinol Metab. 2017;102(5):1661-72. https://doi.org/10.1210/jc.2016-2046.
  12. Tettamanti et al. Prenatal and postnatal medical conditions and the risk of brain tumors in children and adolescents: an international multicenter case-control study. Cancer Epidemiol Biomarkers Prev. 2017;26(1):110-5. https://doi.org/10.1158/1055-9965.EPI-16-0451.
  13. Made et al. Household income and risk-of-poverty of parents of long-term childhood cancer survivors. Pediatr Blood Cancer. 2017;64(8). https://doi.org/10.1002/pbc.26456
  14. Vetsch et al. “Forewarned and forearmed”: Long-term childhood cancer survivors’ and parents’ information needs and implications for survivorship models of care. Patient Education and Counseling. 2017;100(2), 355–363. https://doi.org/10.1016/j.pec.2016.09.013.
  15. Mader et al. Unemployment following childhood cancer-a systematic review and meta-analysis. Dtsch Arztebl Int. 2017;114(47):805-12. https://doi.org/10.3238/arztebl.2017.0805.
  16. Michel et al. Physicians’ experiences with follow-up care of childhood cancer survivors-challenges and needs. Swiss Med Wkly. 2017;147:w14457 https://doi.org/10.4414/smw.2017.14457.

2016

  1. Adel et al. Common genetic variations in cell cycle and DNA repair pathways associated with pediatric brain tumor susceptibility. Oncotarget. 2016;7(39):63640-50.
  2. Adam et al. Socioeconomic disparities in childhood cancer survival in Switzerland. Int J Cancer. 2016;138(12):2856-66.
  3. Christen et al. Preferences for the organization of long-term follow-up in adolescent and young adult cancer survivors. Support Care Cancer. 2016;24(8):3425-36.
  4. Essig et al. Improving Communication in Adolescent Cancer Care: A Multiperspective Study. Pediatr Blood & Cancer. 2016; 63(8):1423-30.
  5. Gianinazzi et al. Cancer’s positive flip side: posttraumatic growth after childhood cancer. Support Care Cancer. 2016; 24(1):195-203.
  6. Kreis et al. Space-time clustering of childhood cancers in Switzerland: A nationwide study. Int J Cancer. 2016;138(9):2127-35.
  7. Lupatsch et al. Temporal association between childhood leukaemia and population growth in Swiss municipalities. Eur J Epidemiol. 2016;31(8):763-74
  8. Lupatsch et al. Follow-Up Care of Adolescent Survivors of Childhood Cancer: The Role of Health Beliefs. Pediatr Blood & Cancer. 2016;63(2):318-25.
  9. Mader et al. Employment Situation of Parents of Long-Term Childhood Cancer Survivors. Plos ONE. 2016;11(3):e0151966.
  10. Mulder et al. Transition guidelines: An important step in the future care for childhood cancer survivors. A comprehensive definition as groundwork. Eur J Cancer. 2016;54:64-8.
  11. Schindler et al. Cause-Specific Long-Term Mortality in Survivors of Childhood Cancer in Switzerland: A Population Based Study. Int J Cancer. 2016;139(2):322-33.
  12. Feijen et al. Late Cardiac Events after Childhood Cancer: Methodological Aspects of the Pan-European Study PanCareSurFup. Plos ONE. 2016;11(9):e0162778.
  13. Vetsch et al. Follow- up care of young childhood cancer survivors: attendance and parental involvement. Support Care Cancer. 2016;24(7):3127-38.
  14. Vienneau et al. A multinational case-control study on childhood brain tumours, anthropogenic factors, birth characteristics and prenatal exposures: A validation of interview data. Cancer Epidemiol. 2016;40:52-59.
  15. Wengenroth et al. Income in Adult Survivors of Childhood Cancer. Plos ONE. 2016;11(5):e0155546.
  16. Michel et al. Preferences for long-term follow-up care in childhood cancer survivors. Eur J Cancer Care (Engl). 2016;25(6):1024-33.

2015

  1. Adam M, Kuehni CE, Spoerri A, Schmidlin K, Gumy-Pause F, Brazzola P, Probst-Hensch N, Zwahlen M. Socioeconomic Status and Childhood Leukemia Incidence in Switzerland. Front Oncol. 2015;5:139.
  2. Adel et al. CCDC26, CDKN2BAS, RTEL1, and TERT Polymorphisms in Pediatric Brain Tumor Susceptibility. Carcinogenesis. 2015;36(8):876-82.
  3. Brown et al. The views of European clinicians on guidelines for long-term follow-up of childhood cancer survivors. Pediatr Blood & Cancer. 2015;62:322–328.
  4. Gianinazzi ME, Rueegg CS, Zimmerman K, Kuehni CE, Michel G. Intra-Rater and Inter-Rater Reliability of a Medical Record Abstraction Study on Transition of Care after Childhood Cancer. Plos ONE. 2015;10(5):e0124290.
  5. Hjorth et al. Survivorship after childhood cancer: Pan- Care: A European network to promote optimal long-term care. European Journal of Cancer. 2015;51(19),1203–1211.
  6. Lupatsch JE, Kuehni CE, Niggli F, Ammann RA, Egger M, Spy- cher BD. Population mixing and the risk of childhood leukaemia in Switzerland: a census-based cohort study. Eur J Epidemiol. 2015;30(12):1287-98.
  7. Magi T, Kuehni CE, Torchetti L, Wengenroth L, Luer S, Frei- Erb M. Use of Complementary and Alternative Medicine in Children with Cancer: A Study at a Swiss University Hospital. Plos ONE. 2015;10(12):e0145787.
  8. Michel G, Vetsch J. Screening for psychological late effects in childhood, adolescent and young adult cancer survivors: a systematic review. Current Opinion in Oncology. 2015;7(4),297-305.
  9. Schindler M, Mitter V, Bergstraesser E, Gumy-Pause F, Michel G, Kuehni CE. Death certificate notifications in the Swiss Childhood Cancer Registry: assessing completeness and registration procedures. Swiss Med Wkly. 2015;145:w14225.
  10. Spycher BD, Feller M, Roosli M, Ammann RA, Diezi M, Egger M, Kuehni CE. Childhood cancer and residential exposure to highways: a nationwide cohort study. Eur J Epidemiol. 2015d;30(12):1263-75.
  11. Spycher et al. Background ionizing radiation and the risk of childhood cancer: a census-based nationwide cohort study. Environ Health Perspect. 2015a;123(6):622-8.
  12. Swerdlow et al. Description of the SAGhE Cohort: A Large European Study of Mortality and Cancer Incidence Risks after Child Treatment with Recombinant Growth Hormone. Horm Res Paediatr. 2015;84(3):172-83.
  13. Vetsch J, Rueegg CS, Gianinazzi ME, von der Weid NX, Michel G. Information provision and information needs in parents of long-term childhood cancer survivors. Pediatr Blood & Cancer. 2015;62 (5),859-866.
  14. Wengenroth et al. Health-related quality of life in young survivors of childhood cancer. Qual Life Res. 2015;24(9):2151-61.
  15. Wengenroth et al. Concentration, working speed and memory: Cognitive problems in young childhood cancer survivors and their siblings. Pediatr Blood & Cancer. 2015; 62(5):875-82.

2014

  1. Essig et al. Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol. 2014;15(8):841-51.
  2. Feijen EL, van der Pal HJ, van Dalen EC, Mulder RL, Bardi E, Kuehni C, Tissing WJ, Kremer LC. A new method to facili- tate valid and consistent grading cardiac events in childhood cancer survivors using medical records. Plos ONE. 2014;9(7): e100432.
  3. Gianinazzi ME, Rueegg CS, von der Weid NX, Niggli FK, Kuehni CE, Michel G. Mental health-care utilization in survivors of childhood cancer and siblings: the Swiss childhood cancer survivor study. Support Care Cancer. 2014;22(2):339-49.
  4. Gianinazzi ME, Essig S, Rueegg CS, von der Weid NX, Brazzo- la P, Kuehni CE, Michel G. Information provision and information needs in adult survivors of  childhood cancer. Pediatr Blood & Cancer. 2014;61(2):312-8.
  5. Hauri DD, Spycher B, Huss A, Zimmermann F, Grotzer M, von der Weid N, Spoerri A, Kuehni CE, Roosli M. Exposure to Radio-Frequency Electromagnetic Fields From Broadcast Transmitters and Risk of Childhood Cancer: A Census-based Cohort Study. Am J Epidemiol. 2014;179(7):843-51.
  6. Shu et al. Atopic conditions and brain tumor risk in children and adolescents – an international case-control study (CEFALO). Ann Oncol. 2014;25(4):902-8.
  7. Terenziani et al. Practices of pediatric oncology and hematology providers regarding fertility issues: A European Survey. Pediatr Blood & Cancer. 2014;61(11),2054–2058.
  8. Wengenroth L, Rueegg CS, Michel G, Essig S, Ammann RA, Bergstraesser E, Kuehni CE. Life partnerships in childhood cancer survivors, their siblings, and the general population. Pediatr Blood & Cancer. 2014;61(3):538-45.

2013

  1. Andersen et al. Patterns of exposure to infectious diseases and social contacts in early life and risk of brain tumours in children and adolescents: an International Case-Control Study (CEFALO). Br J Cancer. 2013;108(11):2346-53.
  2. Gianinazzi ME, Rueegg CS, Wengenroth L, Bergstraesser E, Rischewski J, Ammann RA, Kuehni CE, Michel G. Adolescent survivors of childhood cancer: are they vulnerable for psychological distress? Psycho-oncology. 2013;22(9):2051-8.
  3. Hauri D, Spycher B, Huss A, Zimmermann F, Grotzer M, von der Weid N, Weber D, Spoerri A, Kuehni CE, Röösli M, Domestic radon exposure and risk of childhood cancer: a prospective census-based cohort study. Environ Health Perspect. 2013;121(10):1239-44.
  4. Hauri D, Huss A, Zimmermann F, Kuehni CE, Röösli M. Prediction of residential radon exposure of the whole Swiss population: comparison of model-based predictions with measurement-based predictions. Indoor Air. 2013;23(5):406-16.
  5. Rueegg CS, Gianinazzi ME, Michel G, von der Weid NX, Bergstraesser E, Kuehni CE. Do childhood cancer survivors with physical performance limitations reach healthy activity levels? Pediatr Blood & Cancer. 2013;60(10):1714-20.
  6. Rueegg CS, Gianinazzi ME, Rischewski J, Beck Popovic M, von der Weid NX, Michel G, Kuehni CE. Health-related quality of life in survivors of childhood cancer: the role of chronic health problems. J Cancer Surviv. 2013;7(4):511-22.
  7. Satgé et al. A very rare cancer in Down syndrome: medulloblastoma. Epidemiological data from 13 countries. J Neurooncol. 2013;112(1):107-14.
  8. Singer S, Gianinazzi ME, Hohn A, Kuehni CE, Michel G. General practitioner involvement in follow-up of childhood cancer survivors: a systematic review. Pediatr Blood & Cancer. 2013;60(10):1565-73.
  9. Zimmermann K, Ammann RA, Kuehni CE, De Geest S, Cig- nacco E. Malnutrition in pediatric patients with cancer at diagnosis and throughout therapy: A multicenter cohort study. Pediatr Blood & Cancer. 2013;60(4):642-9.

2012

  1. Aydin D, Feychting M, Schüz J, Röösli M, CEFALO study team. Childhood brain tumours and use of mobile phones: comparison of a case-control study with incidence data. Collaborators: Tynes T, Andersen TV, Schmidt LS, Poulsen AH, Johansen C, Prochazka M, Lannering B, Klæboe L, Eggen T, Jenni D, Grotzer M, Von der Weid N, Kuehni CE. Environ Health. 2012;11:35.
  2. Christensen et al.Brain tumors in children and adolescents and exposure to animals and farm life: a multicenter case-control study (CEFALO). Cancer Causes Control. 2012;23(9).
  3. Essig S, von der Weid NX, Strippoli MPF, Rebholz CE, Michel G, Rueegg CS, Niggli FK, Kuehni CE. Health-related quality of life in long-term survivors of relapsed childhood acute lymphoblastic leukemia: The Swiss Childhood Cancer Survivor Study. Plos ONE. 2012;7(5):e38015.
  4. Essig S, Skinner R, von der Weid NX, Kuehni CE, Michel G. Follow-up programs for childhood cancer survivors in Europe: a questionnaire survey. Plos ONE. 2012;7(12):e53201.
  5. Hauri DD, Huss A, Zimmermann F, Kuehni CE, Roosli M. A prediction model for assessing residential radon concentration in Switzerland. J Environ Radioact. 2012; 112:83-9.
  6. Kuehni et al. Educational achievement in Swiss childhood cancer survivors compared with the general population. Cancer. 2012;118(5):1439-49.
  7. Rebholz CE, Spycher BD, Rueegg CS, Michel G, Ammann R, von der Weid NX, Kuehni CE. Clustering of health behaviours in adult survivors of childhood cancer and the general population. Brit J Cancer. 2012;107(2):234-42.
  8. Rebholz et al. Alcohol consumption and binge drinking in young adult childhood cancer survivors: A report from the Swiss Childhood Cancer Survivor Study. Pediatr Blood & Cancer. 2012;58:256-64.
  9. Rueegg CS, Michel G, Wengenroth L, von der Weid NX, Bergstraesser E, Kuehni CE. Physical performance limitations in adolescent and adult survivors of childhood cancer and their siblings. Plos ONE. 2012;7(10):e47944.
  10. Rueegg CS, Rebholz CE, Michel G, Grotzer M, von der Weid NX, Kuehni CE. Daily physical activity and sport of adult survivors of childhood cancer and healthy control. Plos ONE. 2012;7(4):e34930.

2011

  1. Aydin et al. Impact of random and systematic recall errors and of selection bias in case-control studies on mobile phone use and brain tumors in adolescents (CEFALO study). Bioelectromagnetics. 2011;32:396-407.
  2. Aydin et al. Mobile phone use and brain tumors in children and adolescents: a multicenter case-control study. J Natl Cancer Inst. 2011;1264-76.
  3. Marquis A, Strippoli MPF, Spycher BD, Rebholz CE, von der Weid NX, Kuehni CE. Paracetamol, NSAIDS and risk of asthma in adult survivors of childhood cancer. J Allergy Clin Im- munol. 2011;127:270-2.
  4. Michel G, Kuehni CE, Rebholz CE, Zimmermann K, Eiser C, Rueegg CS, von der Weid NX. Can health beliefs help ex- plaining attendance to follow-up care? The Swiss Childhood Cancer Survivor Study. Psychooncology. 2011;20:1034-43.
  5. Rebholz et al. Health care utilization of long-term survivors of childhood cancer: the British Childhood Cancer Survivor Study.  J Clin Oncol. 2011;29:4181-8.
  6. Rebholz CE, von der Weid NX, Michel G, Niggli F, Kuehni CE. Follow-up care among long-term childhood cancer survivors: a report from the Swiss childhood cancer survivor study. Eur J Cancer. 2011;41:221-9.
  7. Spycher BD, Feller M, Zwahlen M, Röösli M, von der Weid NX, Hengartner H, Egger M, Kuehni CE. Childhood cancer and nuclear power plants in Switzerland: a census-based cohort study. Int J Epidemiol. 2011;40:1247-60.

2010

  1. Adam et al. Access to specialized pediatric cancer care in Switzerland. Pediatr Blood & Cancer. 2010;54:721-7.
  2. Feller M*, Adam M*, Zwahlen M, Brazzola P, Niggli F, Kuehni CE. Family characteristics as risk factors for childhood acute lymphoblastic leukemia. *joint first authorship. PLoS One. 2010;5;e13156.
  3. Marquis, A, Kuehni CE*, Strippoli MPF, Kühne T, Brazzola P. Sperm analysis of patients after successful treatment of childhood acute lymphoblastic leukemia with chemotherapy only. *corresponding author. Pediatr Blood & Cancer. 2010;55:208-10.
  4. Michel G, Rebholz CE, von der Weid NX, Bergstraesser E, Kuehni CE. Psychological distress in adult survivors of childhood cancer: the Swiss Childhood Cancer Survivor Study. J Clin Oncol. 2010;28:1740-8.

2008

  1. Michel G, von der Weid N, Zwahlen M, Redmond S, Strip- poli MPF, Kuehni CE. Incidence of childhood cancer in Switzerland: the Swiss Childhood Cancer Registry. Pediatr Blood & Cancer. 2008; 50:46-51.

2007

  1. Michel G, von der Weid N, Zwahlen M, Adam M, Rebholz CE, Kuehni CE. The Swiss Childhood Cancer Registry: rationale, organisation and results for the years 2001-2005. Swiss Med Wkly. 2007; 137:502-9.
  2. Röösli M, Michel G, Kuehni CE, Spoerri A. Cellular telephone use and time trends in brain tumour mortality in Switzerland from 1969 to 2002. Eur J Cancer Prev. 2007; 16:77-82.

Other publications

  1. Roser K, Erdmann F, Michel G, Winther JF, Mader L. The impact of childhood cancer on parents’ socio-economic situation-A systematic review. Psychooncology. 2019 Jun;28(6):1207-1226. doi: 10.1002/pon.5088.
  2. Brinkman TM, Recklitis CJ, Michel G, Grootenhuis MA, Klosky JL. Psychological symptoms, social outcomes, socioeconomic attainment, and health behaviors among survivors of childhood cancer: Current state of the literature. Journal of Clinical Oncology. 2018;36(21),2190-2197. doi: 10.1200/JCO.2017.76.5552
  3. Bhatia et al. Collaborative Research in Childhood Cancer Survivorship: The Current Landscape. J Clin Oncol. 2015;33(27):3055-64.
  4. Winther et al. Childhood cancer survivor cohorts in Europe. Acta Oncol. 2015;54(5):655-68.
  5. Kuehni C, Spycher BD. Nuclear power plants and childhood leukaemia: lessons from the past and future directions. Swiss Med Wkly. 2014;144:w13912.
  6. Laurier et al. Childhood leukaemia risks: from unexplained findings near nuclear installations to recommendations for future research. J Radiol Prot. 2014;34(3):R53-68.
  7. Kuehni et al. Cohort Profile: The Swiss Childhood Cancer Survivor Study. Int J Epidemiol. 2012;41(6):1553-64. Epub 2012/06/28.2008
  8. Adam M, Rebholz C, Egger M, Zwahlen M, Kuehni CE. Childhood Leukaemia and Socioeconomic Status: what is the evidence? Radiat Prot Dosim. 2008;132:246-54.
  9. Hendriks M*, Belle F*, Tomášiková Z*, Kuehni C, Michel G, von der Weid N; *: shared first autorship. Follow-up Care in Childhood Cancer Survivors: Improving Services in Switzerland. Schweizer Krebsbulletin, Sep 2019
  10. Lupatsch JE, Kreis C, Niggli F, Kuehni CE, Spycher B. 2016. Ursachen von Krebs bei Kindern: Was verrät der Wohnort? Schweizer Krebsbulletin 2016;36(01):29-33.
  11. Wengenroth L, Schindler M, Kuonen R, Kuehni CE. Krebs als Kind oder Teenager: das Leben danach. Schweizer Krebsbulletin 2014;4:292-295.
  12. Michel G, von der Weid NX. Nachsorge nach Krebs im Kindesalter – Pläne für die Schweiz. Schweizer Krebsbulletin 2014;4:296-298
  13. Rueegg CS, Gianinazzi ME, Michel G. Psychosoziale Spätfolgen nach Kinderkrebs – Eine Langzeitstudie des Schweizer Kinderkrebsregisters. Schweizer Krebsbulletin.2013;3, 212-213
  14. Kuehni CE, Mitter V, Niggli F, von der Weid NX. Die Rolle des Kinderkrebsregisters unter dem geplanten Krebsregistrierungsgesetz: Chancen und Risiken. Schweizer Krebsbulletin 2013;3:213-216.
  15. Niggli F, Kuehni CE, Lamontagne-Müller S. Seltene Krebserkrankungen – das tägliche Brot der pädiatrischen Onkologie. Schweizer Krebsbulletin. 2012;4.309-10.
  16. Michel G. Nachsorge nach Krebs im Kindesalter. Schweizer Krebsbulletin. 2012;3:212-213.
  17. Kuehni CE. The Swiss Childhood Cancer Registry: from causes to outcomes. Schweizer Krebsbulletin. 2010;2:129-130.
  18. Kuehni CE, Feller M, Egger M. Response to: Sufficient statistical power for CANUPIS? Bulletin suisse du cancer. 2009;4.09:301.
  19. Kuehni CE, von der Weid NX, Hengartner H, Niggli F, Röösli M, Huss A, Feller M, Egger M. CANUPIS – Childhood Cancer and Nuclear Power Plants in Switzerland. Schweizer Krebsbulletin. 2008;28:264-266.
  20. von der Weid NX, Kuehni CE. Le Registre Suisse du Cancer de l’Enfant: premier Registre du Cancer national. Information de la communauté médicale quant à la nouvelle situation concernant la protection des données. Bulletin des médecins suisses. 2008;89:117-9.
  21. Michel G, Christen S, Roser K. Nachsorge nach Krebs im Jugend-und jungen Erwachsenenalter. Schweizer Zeitschrift für Onkologie 2018;2, 22-24.
  22. Michel G. Psychosoziale Bedürfnisse von ehemaligen Kinderkrebspatienten. Krebsforschung in der Schweiz, Bern, Krebsliga Schweiz 2017;83-86.
  23. Weiss A, Kuehni CE, Michel G, von der Weid NX. 40 Jahre Plattform für Forschung und Monitoring. Das Schweizer Kinderkrebsregister. info@onkologie. 2016;(05):40-42.
  24. Mitter V, Michel G. Krebs bei Kindern. Ein Überblick aus dem Schweizer Kinderkrebsregister. Onkologiepflege 1;5-8.
  25. Ruegg CS, Gianinazzi ME, Michel G. Psychosoziale Spätfolgen nach Kinderkrebs – Eine Langzeitstudie des Schweizer Kinderkrebsregisters. Newsletter Schweizerische Gesellschaft für Psychoonkologie. 21;5-8.
  26. Kuehni CE, Michel G, Egger M, Zwahlen M, Beck Popovic M, Nigglie F, von der Weid NX. Das Schweizer Kinderkrebsregister: Erfahrungen als nationales Krebsregister. Schweizerische Ärztezeitung 2013;94: 327.
  27. Kuehni CE, Niggli FK. Endlich ein nationales Krebsregistrierungsgesetz für Kinder und Erwachsene. Schweizerische Ärztezeitung 2013;94:160.
  28. Michel G. Nachsorge nach Krebs im Kindesalter – ein neues Feld für Pflege?. Onkologiepflege 2011;3:20-23.
  29. Kuehni CE, von der Weid NX. Das Schweizer Kinderkrebsregister als erstes nationales Krebsregister: Information der Ärzteschaft zur neuen Datenschutzsituation. Schweizerische Aerztezeitung. 2008;89:117-9.
  30. Kuehni CE, von der Weid NX. Das Schweizer Kinderkrebsregister als erstes nationales Krebsregister:Informationder Ärzteschaft zur neuen Datenschutzsituation. Paediatrica. 2008;19:53-5.
  31. von der Weid NX, Kuehni CE. Le Registre Suisse du Cancer de l’Enfant: premier Registre du Cancer national. Information de la communauté médicale quant à la nouvelle situation concernant la protection des données. Paediatrica. 2008;19:50-2.
  32. Kuehni CE. Children’s health and the environment. A global perspective (Book review). Paediatrica 2007;15:13-28.